Skip to main content
Download PDF
  • Systematic Review
  • Open access
  • Published:

Excess mortality during the COVID-19 pandemic in low-and lower-middle-income countries: a systematic review and meta-analysis

BMC Public Health volume 24, Article number: 1643 (2024) Cite this article

Abstract

Background

Although the COVID-19 pandemic claimed a great deal of lives, it is still unclear how it affected mortality in low- and lower-middle-income countries (LLMICs). This review summarized the available literature on excess mortality during the COVID-19 pandemic in LLMICs, including methods, sources of data, and potential contributing factors that might have influenced excess mortality.

Methods

We conducted a systematic review and meta-analysis on excess mortality during the COVID-19 pandemic in LLMICs in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines We searched PubMed, Embase, Web of Science, Cochrane Library, Google Scholar, and Scopus. We included studies published from 2019 onwards with a non-COVID-19 period of at least one year as a comparator. The meta-analysis included studies reporting data on population size, as well as observed and expected deaths. We used the Mantel–Haenszel method to estimate the pooled risk ratio with 95% confidence intervals. The protocol was registered in PROSPERO (ID: CRD42022378267).

Results

The review covered 29 countries, with 10 countries included in the meta-analysis. The pooled meta-analysis included 1,405,128,717 individuals, for which 2,152,474 deaths were expected, and 3,555,880 deaths were reported. Calculated excess mortality was 100.3 deaths per 100,000 population per year, with an excess risk of death of 1.65 (95% CI: 1.649, 1.655, p < 0.001). The data sources used in the studies included civil registration systems, surveys, public cemeteries, funeral counts, obituary notifications, burial site imaging, and demographic surveillance systems. The primary techniques used to estimate excess mortality were statistical forecast modelling and geospatial analysis. One out of the 24 studies found higher excess mortality in urban settings.

Conclusion

Our findings demonstrate that excess mortality in LLMICs during the pandemic was substantial. However, estimates of excess mortality are uncertain due to relatively poor data. Understanding the drivers of excess mortality, will require more research using various techniques and data sources.

Peer Review reports

Introduction

Only six viruses within the coronavirus family, namely 229E, NL63, OC43, HKU1, SARS-CoV, and MERS-CoV, have been known to cause respiratory tract infections in humans [1]. The SARS-CoV-2 virus, identified in 2019 as the cause of COVID-19, emerged in Wuhan, China [2]. Despite containment efforts, the virus spread globally, leading the World Health Organization (WHO) to declare it a pandemic in March 2020 [3]. To date, over 6.5 million deaths and 623 million infections have been reported worldwide, with Africa recording nearly 9 million cases and over 173,000 deaths [4].

Numerous non-pharmaceutical interventions were adopted globally to combat COVID-19, such as lockdowns and mask mandates [5,6,7]. While these measures aimed to reduce the transmission of the virus, [8, 9] may have inadvertently increased mortality among chronically ill patients by hindering timely medical care access [10, 11]. Additionally, the pandemic response contributed to higher fatalities from domestic violence, suicide, and mental health issues [9, 12, 13].

Confirmed COVID-19 deaths alone may not fully reflect the pandemic's impact [14]. Excess mortality offers a more comprehensive view, capturing both direct and indirect effects. As per the World Health Organization (WHO), excess mortality is the difference between actual deaths during a crisis and expected deaths without it [15], encompassing COVID-19-related deaths and those indirectly influenced by the pandemic, including socio-economic challenges like compromised food security, disruptions in supply chains, and limited access to healthcare [16,17,18].

Studies have shown that the pandemic exacerbated food insecurity due to lockdowns and economic downturns, which affected the nutritional status and health outcomes of vulnerable populations. Additionally, disruptions in healthcare services led to delays in treatment for chronic conditions and reduced access to essential medical care, further increasing mortality. Mental health issues and increased domestic violence during lockdowns also contributed to higher death rates indirectly associated with the pandemic. These multifaceted impacts highlight the necessity of assessing excess mortality to gain a full understanding of the pandemic's toll, particularly in low- and lower-middle-income countries (LLMICs), where healthcare systems and social safety nets are often less robust. The estimated excess mortality rate from COVID-19 could be 5 to 25-fold higher than reported COVID-19 mortality rates [14].

Understanding and accurately reporting mortality statistics is crucial for global health policy and resource allocation. In low- and lower-middle-income countries (LLMICs), mortality reporting remains a significant challenge. These countries often face systemic challenges, including incomplete civil registration systems, and under-resourced statistical offices, which contribute to incomplete or inaccurate mortality data. Hence knowledge on excess mortality during the COVID-19 pandemic in LLMICs remains limited [19,20,21,22]. Vital registration systems and other data sources are often incomplete or inaccurate, lacking routine mortality reporting [5, 20, 23]. To address these limitations, various methods like data interpolation and extrapolation have been proposed [24]. Innovative approaches such as using satellite imagery to track new graves and participatory epidemiology have also been employed to estimate excess mortality [25,26,27] and these unique circumstances and innovative solutions emerging from LLMICs require focused attention.

In addition, to estimating excess mortality using available data, Shang et al. observed a higher pooled excess mortality in developing countries compared to developed ones but did not delve into specific LLMIC results or assess methodologies and data in these contexts [28]. This systematic review and meta-analysis presents a focused and current summary of excess mortality literature in LLMICs. This study helps to fill a critical gap in the literature by systematically reviewing and analyzing excess mortality in LLMICs during the COVID-19 pandemic. This will not only enhance our understanding of the pandemic's true impact but also support the development of more effective public health responses in these vulnerable regions.The objectives included summarizing existing studies on excess mortality during the COVID-19 pandemic, describing estimation methods and data sources, and identifying drivers of excess mortality in these settings.

Methods

Settings

This systematic review and meta-analysis focused on studies from low- and lower-middle-income countries.

This review, guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [29], focused on estimating excess mortality levels, examining the methodologies and data used for estimation, and identifying factors influencing excess mortality in LLMICs. Quantitative methods were utilized to conduct a meta-analysis, providing a summary estimate of the excess mortality.

Protocol registration

The protocol for conducting this systematic review and meta-analysis was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD42022378267).

Searches

We conducted searches in electronic bibliographic databases including PubMed, Embase, Web of Science, Cochrane Library, Google Scholar, and Scopus. Additionally, we reviewed the reference lists of included studies and relevant publications. The search strategy comprised terms related to key review concepts: COVID-19 and/or SARS-CoV-2, excess mortality, and low- and lower-middle-income countries. Each term was operationalized with various synonyms and tailored for specific databases. The search strategy used Medical Subject Headings (MeSH) terms and involved key terms with the appropriate Boolean operators (AND, OR) to ensure comprehensive coverage.

No language restrictions were applied, and the searches were restricted to studies published between 2019 and the date of the searches. In September 2023, the searches were rerun before the final analyses, resulting in additional studies for inclusion.

Study selection procedures

The inclusion and exclusion criteria were defined based on the Participants, Intervention/Exposure, Comparator, and Outcome (PICO) framework, as detailed below:

Participants/population

The review included population-level or cohort studies from LLMICs, independent of the administrative level (district, region, nation). Facility-based studies were considered to examine covariates and the methods used, but disease-specific studies were excluded.

Intervention(s)/exposure

The exposure of interest was the COVID-19 pandemic. This referred to the period from when the WHO declared COVID-19 a pandemic on March 11, 2020, to the most current wave of COVID-19 infection that was reported in the population under review.

Comparator(s)/control

The comparator in the estimation of the excess mortality was all-cause mortality in the non-COVID-19 period (registered or estimated). This comparator period included data from at least one year before March 2020.

Main outcome

The main review outcome was excess mortality in the population under investigation.

Additional outcome

Additional outcomes included the methods and data sources used in estimating excess mortality and factors that influenced excess mortality in LLMICs.

Eligibility criteria

  1. 1.

    Articles that reported on excess mortality with the COVID-19 pandemic as the exposure of interest

  2. 2.

    Articles conducted in Low and Lower-Middle Income Countries as defined by the World Bank

  3. 3.

    Studies published between the years 2019 and to date

  4. 4.

    Population-level, cohort studies or facility-based studies, independent of the administrative level (district, region, nation)

  5. 5.

    Studies with a comparator of all-cause mortality in the non-COVID-19 period being at least one year before March 2020

Study inclusion

Two independent investigators (JMG and OL) used the eligibility criteria to select studies for inclusion in the review. Any disagreement was resolved by discussion and/or a third reviewer (WQ) was consulted for a consensus to be reached. A meta-analysis was conducted for a subset of the included studies in the review. Studies were included in the meta-analysis only if they provided the following information: a clearly defined estimate for excess mortality, a documented method for estimating excess mortality, a specified population size for the study, as well as an observed, and expected death count for the period reported.

Data extraction

We extracted the following data: author (s), publication year, study country, study period, World Bank income level, estimated excess mortality, disaggregated results for differences in socio-economic groups, estimated and registered COVID-19 mortality, mortality data sources, methods used to estimate excess mortality, identified drivers of excess mortality, type of population (geographical region, cohort), and population baseline characteristics. Mendeley Desktop Version 1.19.8 was used to identify duplicate records.

Measures of effect

The review’s primary outcome was estimated excess mortality as reported in primary studies. Studies that did not indicate the expected (i.e. baseline) deaths and the observed/estimated deaths were not included in the meta-analysis. Secondary outcomes included methods for estimating excess mortality, disaggregated measures of excess mortality (e.g. mortality by socio-economic status) and factors influencing excess mortality.

Data analysis and synthesis

Reported estimates of excess mortality were summarized in tabular format and synthesized narratively. The methods and data that were used for estimating excess mortality and identifying factors that influenced excess mortality, and the socioeconomic disparities in the estimates of excess mortality were summarized and synthesized into thematic narratives.

A meta-analysis was conducted to estimate the rate of excess mortality in LLMICs. Data analysis was conducted using StataSE 16 statistical software from StataCorp, College Station, Texas, USA.. Mortality rates estimated before and during the pandemic were calculated and summarized. The Mantel–Haenszel random-effects method was adopted to estimate the pooled risk ratio at 95% confidence intervals (CIs) and heterogeneity among the studies was estimated using I2 values. The I2 quantified the degree of heterogeneity in the meta-analysis.

Sensitivity analysis

Sensitivity analyses were carried out to investigate how non-eligible research may have an impact on risk differences. This was accomplished by running the data through a meta-analysis twice. For studies that did not have full details based on the eligibility criteria, first, we included all studies and second, only included those that were known to be eligible. Only studies that were known to be eligible were included in the final meta-analysis.

Risk of bias (quality) assessment

The quality of the included studies was assessed using appropriate tools. Quality assessment was performed by two independent reviewers based on the Newcastle- Ottawa Scale (NOS) score and any disparity was solved by discussion and/or consulting a third reviewer (Appendix 1). In this assessment, all studies included in the review and meta-analysis were at minimal risk of bias. In addition to the NOS score, we also considered the methodological rigor of each study, including factors such as study design, sample size, and data collection methods. This comprehensive assessment ensured a thorough evaluation of the quality of the included studies and provided confidence in the robustness of our findings.

Results

Study selection procedures

Figure 1 summarizes the results of the study search and selection process. A total of 10,196 studies were identified in the databases after removal of duplicates. During title and abstract screening, 10,068 were excluded, leaving 129 studies for full-text review, of which, 24 studies were included in the systematic review and 6 in the meta-analysis.

Fig. 1
figure 1

Flow diagram of the study selection procedure

Full size image

The main reasons for exclusion in the review were (1) Reports outside the study scope, (2) Studies not related to review objectives, (3) estimation of excess mortality among patients with a specific disease instead of a population and/or cohort, and (4) the use of a comparator which was less than 1 year in the estimation of the expected number of deaths in the calculation of excess mortality. The main reasons for exclusion from the meta-analysis were that studies did not specify the population size, the number of expected deaths (all-cause mortality), the number of observed deaths, or the methods for estimating excess mortality.

Characteristics of included eligible studies

The characteristics of the 24 included studies are summarized in Table 1. Studies were published between 2020 and 2023 but most were published in 2021 (13 studies). Five studies were conducted in low-income countries and 19 in lower-middle-income countries (Fig. 2). Most of the studies were conducted in Asia, including Iran (7). India (4), Bangladesh (2), and Indonesia (2). There were 6 studies from Africa and none from Latin America or the Caribbean. Sanmarchi et al. [30] reported estimates from 5 countries, making it a total of 29 countries in the review (Fig. 3).

Table 1 Study characteristics of included studies
Full size table
Fig. 2
figure 2

Number of studies classified by World Bank income level

Full size image
Fig. 3
figure 3

Countries and their represented number of included number of studies

Full size image

For the meta-analysis, 10 countries were included from 6 studies. In 7 countries, the observed deaths were higher than expected ([India (2), Iran (1), Kyrgyzstan (1), Uzbekistan (1), Tunisia(1), and Bolivia (1)]. In three countries (Indonesia, Kenya and Mongolia), negative excess mortality was recorded, thus the observed deaths were lower than the number expected in the absence of the pandemic.

Estimate of excess mortality in LLMICs

Table 2 provides an overview of population and mortality data reported by the studies included in the meta-analysis. During the COVID-19 pandemic, of the total 1,398,858,717 individuals/populations, 3,555,880 all-cause deaths were reported, while 2,152,474 deaths were expected from the eleven countries. The pooled excess mortality was 100.3 deaths per 100,000 population. The excess risk of death was 1.65 (95% CI: 1.649, 1.655 p < 0.001). There was a high heterogeneity as indicated by the I2 of 100% among the studies (Fig. 4).

Table 2 Studies included in meta-analysis (n = 10)
Full size table
Fig. 4
figure 4

Adjusted Pooled estimate of excess mortality

Full size image

In 7 countries, the observed deaths were higher than expected, whilst, in three countries, negative excess mortality was recorded, thus the observed deaths were lower than the number expected in the absence of the pandemic.

Methods in estimating excess mortality in LLMICs

The 24 articles used four distinct methods/study designs to determine excess mortality. The largest group of studies (15 articles) used retrospective data of already existing mortality datasets [Bangladesh (1), Iran (5), India (4), Kenya(1); Syria(1), Madagascar(1), Indonesia(1), Uganda(1)] to estimate excess mortality. Two studies used quantification of burial sites by observing the increase in the number of burial grounds to estimate excess mortality [Yemen(1), Somalia(1)]. One study used a cross-sectional survey through a household census (Bangladesh) and another used grey literature (use of already published figures from journalists and organizations) (India) to estimate excess mortality.

Concerning the source of data, four studies used more than one data source to estimate excess mortality. This included burials in public cemeteries + civil death registration + health authority death registration (Indonesia), daily mortality/incidence data from the Syrian Ministry of Health + Excess all-cause mortality data from a statement by the Damascus governorate + obituary notification data from Facebook page (Syria), National survey data + health facility deaths Jha et al. [49] (India) and figures published by regional governments and Indian journalists + government hospital data + funeral counts + handwritten death registers (India).

All other studies relied on only one data source. Five studies used National Civil Registration Data (4 studies from Iran and 1 India). Two studies each used the Health and Demographic Surveillance System (Kenya and Bangladesh), death registers (India and Madagascar) and imaging of burial sites/grounds (a study each from Yemen and Somalia). One study (in Bangladesh) used only primary data (census/survey) data and another study (in Iran and Indonesis) used Bureau of Vital Statistics data to estimate excess mortality.

Studies used several different methods to determine the expected deaths that were used to calculate excess mortality. Twelve studies used modelling techniques to estimate excess mortality. Of these, five studies used linear regression [India(2), Indonesia(1); Iran(2)], two studies used auto-regression modelling techniques. Two other studies (In Madagascar and Iran) used geospatial analysis which involves identifying new grave plots and measuring changes in burial surface area over a period ( In Yemen and Somalia) and two studies used estimation of death counts (In Uganda and Indonesia). Other modelling techniques used included Cox proportional hazard models, Auto-Regressive Integrated Moving Average, model fit, multilevel regression model (full bayesian model).

Factors influencing excess mortality in LLMICs

In assessing the factors that might have influenced excess mortality, of the 24 studies, only one (in India) reported differences in mortality between rural and urban areas. They found that excess deaths in the first wave of the pandemic were concentrated in urban areas, while deaths in the second wave affected both urban and rural areas. Other studies speculated what could have caused excess morality without empirical evidence in their data. No study reported disaggregated information by socio-economic status.

Discussion of key findings

This is the first systematic review and meta-analysis of studies estimating excess mortality during the COVID-19 pandemic in low- and lower-middle-income countries (LLMICs), exploring methods in estimating excess mortality and the factors that might have influenced excess morality in LLMICs.

The results of the meta-analysis indicate that excess mortality in LLMICs was substantial. There were an estimated 1,403,406 excess deaths in the 10 countries covered by the included studies, representing 100.3 excess deaths per 100,000 population or a 1.65 excess risk of death (95% CI: 1.649, 1.655 p < 0.001) during the pandemic. Expected deaths were mostly estimated based on secondary data analysis. Other studies quantified an increase in burial grounds and other household surveys. This review identified only one study that assessed factors associated with excess mortality. According to that study, excess deaths were concentrated in urban areas during the first wave of the pandemic but affected both urban and rural areas in the second wave [49].

A previous review and meta-analysis of global excess mortality reported a slightly higher estimate of excess mortality for lower-middle-income countries [133.45 (95% CI: 75.10–189.38) per 100,000]. Also, according to the COVID-19 Excess Mortality Collaborators, globally, the number of excess deaths due to the COVID-19 pandemic was largest in the regions of South Asia, north Africa the Middle East, and Eastern Europe. India (4·07 million [3·71–4·36]), the USA (1·13 million [1·08–1·18]), Russia (1·07 million [1·06–1·08]), Mexico (798,000 [741000–867000]), Brazil (792,000 [730000–847000]), Indonesia (736,000 [594000–955000]), and Pakistan (664,000 [498000–847000]) were estimated to have the highest cumulative excess deaths due to COVID-19 at the national level. They highlighted that across countries, the ratios showed significant variation, with New Zealand having the lowest at -17.10 (-26.06 to -8.84) and the Central African Republic the highest at 139.24 (88.86–213.67). South Africa, the only sub-Saharan African nation with available direct estimates of excess mortality from vital registration data, had a ratio of 3.31 (3.15–3.64). In South Asia, national-level ratios ranged from 8.33 (7.58–8.92) in India to 36.06 (15.14–53.25) in Bhutan. Within India and Pakistan, the most extreme ratios were observed at the state and province level, spanning from 0.96 (0.44–1.41) in Goa, India to 49.64 (28.94–72.74) in Balochistan, Pakistan [50].

By examining the methods employed in estimating excess mortality, we provide valuable insights into the diverse approaches used in LLMIC contexts. Notably, innovative techniques such as quantifying burial sites and utilizing geospatial analysis emerged during the pandemic, offering alternative means of mortality surveillance in resource-constrained settings. The methods of studies included in this review align with the methods of other studies conducted in high-income countries. 50− Retrospective data analysis, while essential for calculating excess mortality, can be limited by delays in death registration, leading to potential underestimation at the time of analysis. This design was however suitable at the time of the pandemic and further corresponded to WHO recommendations.53 Estimating excess mortality requires an estimate of a certain level of baseline mortality to enable computation of excess mortality. Quantification of burial sites using geospatial analysis is a new method that emerged during the pandemic and was found to have considerable advantages for rapidly monitoring population mortality in settings without effective vital registrations [25]. However, this method could result in underestimation due to moderate precision because of missing grave counts in satellite images [26].

A few studies used burial site expansion before and after the pandemic to quantify excess mortality.

Some studies from the review used a combination of two or more methods, ranging from death registries, burial ground quantifications, journal reports and demographic survey data. The use of multiple methods is not new. It has been used in other studies [32, 51]. In this current review, linear regression models were widely used to estimate the number of deaths that would have occurred in the absence of the pandemic. This aligns with other estimation methods proven to be statistically efficient in estimating excess mortality [34].

There is relatively limited information on factors that influence excess mortality in LLMICs. Only one study included in our review [52] reported that excess mortality was associated with sociodemographic and clinical characteristics. [34], whereas in several high-income countries, socioeconomic disparity in excess mortality has been studied extensively. In England for example, it was observed that excess mortality was consistently higher for essential workers throughout 2020, particularly for healthcare workers [39]. In Korea, the pandemic has disproportionately affected those of lower socioeconomic status and has exacerbated inequalities in mortality [37]. Unfortunately, similar evidence is unavailable for LLMICs.

In this study, it is evident that the overall estimate is greatly influenced by the data from India due to its significant population size, constituting 65% of the weight. Consequently, the observed excess mortality rates in other countries appear considerably lower. This substantial variance could potentially be attributed to this influential factor for the high rates of excess mortality in LLMICs. It is plausible to speculate that excess mortality has been impacted by a wide range of factors, including limited health sector capacities to detect and treat COVID-19, more constrained resources to take care of other diseases, and fewer resources to cushion the negative social consequences of the pandemic [14].

The findings of this review reconfirm that the true impact of the pandemic is considerably higher than the reported number of COVID-19 deaths, which have been estimated at 100.3 /100,000 for the 10 LLMICs covered by studies included in our meta-analysis. Overall, our review shows the importance of addressing excess mortality in LLMICs and provides a foundation for ongoing research and policy initiatives aimed at improving pandemic preparedness and response strategies in these settings.

Our review has some limitations. First, a low number of primary studies met the criteria for inclusion and large variation in methods of included studies limited our ability to include studies in the meta-analysis. Second, our results are not representative of all LLMICs given insufficient numbers of studies from some parts of the world. Nevertheless, the results of this study provide a better understanding of the effect of the pandemic on mortality in LLMICs and may inform future analyses of excess mortality. The need to enhance death registration systems in LLMICs is essential for better pandemic monitoring.

Conclusion

Our review shows that excess mortality during the COVID-19 pandemic was substantial in LLMICs. It was above excess mortality levels reported for HIC and much higher than reported COVID-19 deaths in LLMIC. Most studies used retrospective and linear regression models to estimate excess mortality. More research and better data are needed to identify the drivers of excess mortality in LLMICs.

Availability of data and materials

No datasets were generated or analysed during the current study.

Abbreviations

ACM:

All-Cause Mortality

BUA:

Berlin University Alliance

COVID-19:

Coronavirus Disease 2019

G-WAC:

German-West African Centre for Global Health and Pandemic Prevention

HICs:

High-Income Countries

LIC:

Low-Income Countries

LMICs:

Lower-Middle-Income Countries

LLMICs:

Low- and Lower-Middle-Income Countries

NOS:

Newcastle–Ottawa Scale

PRISMA:

Preferred Reporting Items for Systematic Review and Meta-Analysis

PICO:

Participants, Intervention, Comparator, and Outcome

WHO:

World Health Organization

References

  1. Liu DX, Liang JQ, Fung TS. Human coronavirus-229E,-OC43,-NL63, and-HKU1 (Coronaviridae). Encyclopedia Virol. 2021;5:428.

  2. Ludwig S, Zarbock A. Coronaviruses and SARS-CoV-2: a brief overview. Anesth Analg. 2020;131(1):93–6.

    Article  CAS  PubMed  Google Scholar 

  3. WHO T. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. Geneva, Switzerland. 2020 Mar 11:3-5.World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2022. Available online: https://covid19.who.int/. Accessed 24 Oct 2022.

  4. Karlinsky A, Kobak D. Tracking excess mortality across countries during the COVID-19 pandemic with the world mortality dataset. Elife. 2021;10:e69336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kung S, Doppen M, Black M, Hills T, Kearns N. Reduced mortality in New Zealand during the COVID-19 pandemic. The Lancet. 2021;397(10268):25.

    Article  CAS  Google Scholar 

  6. Frempong NK, Acheampong T, Apenteng OO, Nakua E, Amuasi JH. Does the data tell the true story? A modelling assessment of early COVID-19 pandemic suppression and mitigation strategies in Ghana. PLoS One. 2021;16(10):e0258164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Faust JS, Du C, Mayes KD, Li SX, Lin Z, Barnett ML, Krumholz HM. Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic, March-August 2020. JAMA. 2021;326(1):84–6.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kirpich A, Shishkin A, Weppelmann TA, Tchernov AP, Skums P, Gankin Y. Excess mortality in Belarus during the COVID-19 pandemic as the case study of a country with limited non-pharmaceutical interventions and limited reporting. Sci Rep. 2022;12(1):5475.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Antonio-Villa NE, Fernandez-Chirino L, Pisanty-Alatorre J, Mancilla-Galindo J, Kammar-García A, Vargas-Vázquez A, González-Díaz A, Fermín-Martínez CA, Márquez-Salinas A, Guerra EC, Bahena-López JP. Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the coronavirus disease 2019 (COVID-19) pandemic in Mexico City. Clin Infect Dis. 2022;74(5):785–92.

    Article  CAS  PubMed  Google Scholar 

  10. Gobiņa I, Avotiņš A, Kojalo U, Strēle I, Pildava S, Villeruša A, Briģis Ģ. Excess mortality associated with the COVID-19 pandemic in Latvia: a population-level analysis of all-cause and noncommunicable disease deaths in 2020. BMC Public Health. 2022;22(1):1109.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Tanaka T, Okamoto S. Increase in suicide following an initial decline during the COVID-19 pandemic in Japan. Nat Hum Behav. 2021;5(2):229–38.

    Article  PubMed  Google Scholar 

  12. Sun S, Cao W, Ge Y, Siegel M, Wellenius GA. Analysis of firearm violence during the COVID-19 pandemic in the US. JAMA Netw Open. 2022;5(4):e229393-.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, Aravkin AY, Bisignano C, Barber RM, Alam T, Fuller JE. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399(10334):1513–36.

    Article  CAS  Google Scholar 

  14. World Health Organization. Humanitarian Health Action. Definitions: Emergencies. 2008. https://www.who.int/hac/about/definitions/en/.

  15. Helleringer S, Queiroz BL. Commentary: Measuring excess mortality due to the COVID-19 pandemic: progress and persistent challenges. Int J Epidemiol. 2022;51(1):85–7.

    Article  PubMed  Google Scholar 

  16. Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613(7942):130–7.

    Article  CAS  PubMed  Google Scholar 

  17. Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, Soman S, Besançon L, Kashnitsky I, Ganesh S, McLaughlin A. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Glob Health. 2022;7(5):e008477.

    Article  PubMed  Google Scholar 

  18. Lewnard JA, Mahmud A, Narayan T, Wahl B, Selvavinayagam TS, Laxminarayan R. All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study. Lancet Infect Dis. 2022;22(4):463–72.

    Article  CAS  PubMed  Google Scholar 

  19. Gupta A. COVID-19 and the importance of improving civil registration in India. New Delhi: Center for the Advanced Study of India; 2020.

    Google Scholar 

  20. Sempé L, Lloyd-Sherlock P, Martínez R, Ebrahim S, McKee M, Acosta E. Estimation of all-cause excess mortality by age-specific mortality patterns for countries with incomplete vital statistics: a population-based study of the case of Peru during the first wave of the COVID-19 pandemic. Lancet Reg Health-Am. 2021;1:2.

    Google Scholar 

  21. Koum Besson ES, Norris A, Bin Ghouth AS, Freemantle T, Alhaffar M, Vazquez Y, Reeve C, Curran PJ, Checchi F. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate. Yemen BMJ Glob Health. 2021;6(3):e004564–e004564.

    Article  PubMed  Google Scholar 

  22. Warsame A, Bashiir F, Freemantle T, Williams C, Vazquez Y, Reeve C, Aweis A, Ahmed M, Checchi F, Dalmar A. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia. Int J Infect Dis. 2021;1(113):190–9.

    Article  Google Scholar 

  23. Barnwal P, Yao Y, Wang Y, Juy NA, Raihan S, Haque MA, van Geen A. Assessment of excess mortality and household income in rural Bangladesh during the COVID-19 pandemic in 2020. JAMA Netw Open. 2021;4(11):e2132777-.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Acosta RJ, Patnaik B, Buckee C, Kiang MV, Irizarry RA, Balsari S, Mahmud AS. All-cause excess mortality in the State of Gujarat, India, during the COVID-19 pandemic (March 2020-April 2021). medRxiv. 2021:2021.08.25.21262562.

  25. Banaji M. Estimating COVID-19 infection fatality rate in Mumbai during 2020. medRxiv. 2021:2021.04.05.21254855.

  26. Murhekar MV, Bhatnagar T, Thangaraj JW, Saravanakumar V, Kumar MS, Selvaraju S, Rade K, Kumar CG, Sabarinathan R, Turuk A, Asthana S. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021. Int J Infect Dis. 2021;1(108):145–55.

    Article  Google Scholar 

  27. Shang W, Wang Y, Yuan J, Guo Z, Liu J, Liu M. Global excess mortality during COVID-19 pandemic: a systematic review and meta-analysis. Vaccines. 2022;10(10):1702.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:372.

    Google Scholar 

  29. Matz M, Allemani C, van Tongeren M, Nafilyan V, Rhodes S, van Veldhoven K, Pembrey L, Coleman MP, Pearce N. Excess mortality among essential workers in England and Wales during the COVID-19 pandemic. J Epidemiol Community Health. 2022;76(7):660–6.

    Article  PubMed  Google Scholar 

  30. Oh J, Min J, Kang C, Kim E, Lee JP, Kim H, Lee W. Excess mortality and the COVID-19 pandemic: causes of death and social inequalities. BMC Public Health. 2022;22(1):2293.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hedstrom A, Mubiri P, Nyonyintono J, Nakakande J, Magnusson B, Vaughan M, Waiswa P, Batra M. Impact of the early COVID-19 pandemic on outcomes in a rural Ugandan neonatal unit: a retrospective cohort study. PLoS ONE. 2021;16(12):e0260006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Besson ES, Norris A, Ghouth AS, Freemantle T, Alhaffar M, Vazquez Y, Reeve C, Curran PJ, Checchi F. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, Yemen. BMJ Glob Health. 2021;6(3):e004564.

    Article  Google Scholar 

  33. Hanifi SM, Alam SS, Shuma SS, Reidpath DD. Insights into excess mortality during the first months of the COVID-19 pandemic from a rural, demographic surveillance site in Bangladesh. Front Public Health. 2021;29(9):622379.

    Article  Google Scholar 

  34. Jha P, Deshmukh Y, Tumbe C, Suraweera W, Bhowmick A, Sharma S, Novosad P, Fu SH, Newcombe L, Gelband H, Brown P. COVID mortality in India: National survey data and health facility deaths. Science. 2022;375(6581):667–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tadbiri H, Moradi-Lakeh M, Naghavi M. All-cause excess mortality and COVID-19-related deaths in Iran. Med J Islam Repub Iran. 2020;34:80.

    PubMed  PubMed Central  Google Scholar 

  36. Ghafari M, Watson OJ, Karlinsky A, Ferretti L, Katzourakis A. A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data. Nat Commun. 2022;13(1):3015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Otiende M, Bauni E, Nyaguara A, Amadi D, Nyundo C, Tsory E, Walumbe D, Kinuthia M, Kihuha N, Kahindi M, Nyutu G. Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysis. Wellcome Open Res. 2021;6:327.

    Article  PubMed  Google Scholar 

  38. Watson OJ, Alhaffar M, Mehchy Z, Whittaker C, Akil Z, Brazeau NF, Cuomo-Dannenburg G, Hamlet A, Thompson HA, Baguelin M, FitzJohn RG. Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria. Nat Commun. 2021;12(1):2394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Safavi-Naini SA, Farsi Y, Alali WQ, Solhpour A, Pourhoseingholi MA. Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013–September 2021): age and sex disaggregated time series analysis. BMC Res Notes. 2022;15(1):130.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Ghafari M, Kadivar A, Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: a province-level analysis. Int J Infect Dis. 2021;1(107):101–15.

    Article  Google Scholar 

  41. Rasambainarivo F, Rasoanomenjanahary A, Rabarison JH, Ramiadantsoa T, Ratovoson R, Randremanana R, Randrianarisoa S, Rajeev M, Masquelier B, Heraud JM, Metcalf CJ. Monitoring for outbreak-associated excess mortality in an African city: detection limits in Antananarivo. Madagascar Intern J Infect Dis. 2021;1(103):338–42.

    Article  Google Scholar 

  42. Wijaya MY. The estimation of excess mortality during the COVID-19 pandemic in Jakarta, Indonesia. Kesmas. 2022;17(1).

  43. Leffler CT, Das S, Yang E, Konda S. Preliminary analysis of excess mortality in India during the COVID-19 pandemic. Am J Trop Med Hyg. 2022;106(5):1507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Elyazar IR, Surendra H, Ekawati LL, Djaafara BA, Nurhasim A, Arif A, Hidayana I, Oktavia D, Adrian V, Salama N, Hamdi I. Excess mortality during the first ten months of COVID-19 epidemic at Jakarta, Indonesia. Int J Infect Dis. 2023;130.

  45. Sanmarchi F, Golinelli D, Lenzi J, Esposito F, Capodici A, Reno C, Gibertoni D. Exploring the gap between excess mortality and COVID-19 deaths in 67 countries. JAMA Network Open. 2021;4(7):e2117359-.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Esmaeilzadeh N, Hoseini SJ, Nejad-Bajestani MJ, Shakeri M, Mood ZI, Hoseinzadeh H, Dooghaee MH. Excess mortality in Northeast Iran caused by COVID-19: Neglect of offset community transformations of health. Asian Pac J Trop Med. 2023;16(6):261–7.

    Article  Google Scholar 

  47. Oduor C, Audi A, Kiplangat S, Auko J, Ouma A, Aol G, Nasimiyu C, O. Agogo G, Lo T, Munyua P, Herman-Roloff A. Estimating excess mortality during the COVID-19 pandemic from a population-based infectious disease surveillance in two diverse populations in Kenya, March 2020-December 2021. PLOS Glob Public Health. 2023;3(8):e0002141.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ebrahimoghli R, Abbasi-Ghahramanloo A, Moradi-Asl E, Adham D. The COVID-19 pandemic’s true death toll in Iran after two years: an interrupted time series analysis of weekly all-cause mortality data. BMC Public Health. 2023;23(1):442.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Rabarison JH, Rakotondramanga JM, Ratovoson R, Masquelier B, Rasoanomenjanahary AM, Dreyfus A, Garchitorena A, Rasambainarivo F, Razanajatovo NH, Andriamandimby SF, Metcalf CJ. Excess mortality associated with the COVID-19 pandemic during the 2020 and 2021 waves in Antananarivo, Madagascar. BMJ Glob Health. 2023;8(7):e011801.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Jung E, Ro YS, Ryu HH, Do Shin S, Moon S. Interaction effects between COVID-19 outbreak and community income levels on excess mortality among patients visiting emergency departments. J Korean Med Sci. 2021;36(13):e100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Ghafari M, Hejazi B, Karshenas A, Dascalu S, Kadvidar A, Khosravi MA, Abbasalipour M, Heydari M, Zeinali S, Ferretti L, Ledda A. Lessons for preparedness and reasons for concern from the early COVID-19 epidemic in Iran. Epidemics. 2021;1(36):100472.

    Article  Google Scholar 

  52. Strongman H, Carreira H, De Stavola BL, Bhaskaran K, Leon DA. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: a time series analysis using the clinical practice research datalink. PLoS Med. 2022;19(1):e1003870.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

A big thank you to the management of the German-West African Centre for Global Health and Pandemic Prevention (G-WAC) / Berlin University Alliance (BUA) for their financial and technical support. I extend my sincere thanks to the leadership of the Global Health and Infectious Diseases Research Group at the Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana for their understanding in excusing the Principal Investigator (JMG) to carry out this study.

Funding

The work has been made possible by the German-West African Centre for Global Health and Pandemic Prevention (G-WAC) scholarship of the German Academic Exchange Service (DAAD) as part of the Global Centres Programme funded by the German Federal Foreign Office. Additional financial support for supervision was made available by the Flattening the Curve Project of the Berlin University Alliance (BUA).

Author information

Authors and Affiliations

  1. School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

    Jonathan Mawutor Gmanyami, Oscar Lambert & John Humphrey Amuasi

  2. German West-African Centre for Global Health and Pandemic Prevention, Berlin, Germany

    Jonathan Mawutor Gmanyami, Wilm Quentin & John Humphrey Amuasi

  3. Global Health and Infectious Diseases Research Group, Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana

    Jonathan Mawutor Gmanyami & John Humphrey Amuasi

  4. Department of Health Care Management, Technische Universität Berlin, Berlin, Germany

    Wilm Quentin

  5. Chair of Planetary & Public Health, University of Bayreuth, Bayreuth, Germany

    Wilm Quentin

  6. Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany

    Andrzej Jarynowski & Vitaly Belik

  7. Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

    John Humphrey Amuasi

Authors
  1. Jonathan Mawutor Gmanyami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilm Quentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Oscar Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrzej Jarynowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vitaly Belik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John Humphrey Amuasi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JMG, JHA, WQ, AJ and VB made substantial contributions to the conception and design of this systematic review and meta-analysis. JMG performed the screening, study selection and data extraction from all studies using the eligibility criteria. OL independently screened the titles and abstracts of the identified studies. All authors approved the final version of this manuscript.

Corresponding author

Correspondence to Jonathan Mawutor Gmanyami.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gmanyami, J.M., Quentin, W., Lambert, O. et al. Excess mortality during the COVID-19 pandemic in low-and lower-middle-income countries: a systematic review and meta-analysis. BMC Public Health 24, 1643 (2024). https://doi.org/10.1186/s12889-024-19154-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-19154-w

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us